Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma

NCT01207921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease

Interventions

DRUG: Lenalidomide

Sponsor

Washington University School of Medicine

Collaborators

[object Object]